Premenstrual Dysphoric Disorder study, Rush University Medical Center, Chicago

Premenstrual dysphoric disorder (PMDD) is one of the most common conditions affecting women of reproductive age having a high impact on personal well-being and professional productivity. The purpose of this study is to explore the relationship between inhibin B, a new marker of ovarian function, and PMDD. Participation in the study includes a short orientation at Rush University Medical Center in Chicago, a physical examination including lab work (paid for by the study), an emotional health history interview, completion of a daily questionnaire for two menstrual cycles, at least three blood draws during each menstrual cycle (a phlebotomist can come to your home), and in-home ovulation testing.
Women who complete the study will receive $100.

You may be eligible to participate in this study if you:

Are a Hispanic, black or white woman 18 to 53 years of age with regular menstrual cycles
Currently have premenstrual syndrome (PMS) or premenstrual dysphoric disorder (PMDD)
Are not taking hormones, including oral birth control pills
Are not taking a prescribed medication for an emotional or nervous problem

This is a partial list of eligibility requirements. To inquire about your eligibility, please call the contact number provided. If you wish to inquire via e-mail, please include the title of the study in your message.